Literature DB >> 3570963

New piericidin glucosides, glucopiericidins A and B.

M Matsumoto, K Mogi, K Nagaoka, S Ishizeki, R Kawahara, T Nakashima.   

Abstract

The new piericidin group antibiotics, glucopiericidins A and B were isolated from the culture broth of Streptomyces pactum S48727 (FERM P-8117) as co-metabolite of piericidin A1. The structures of glucopiericidins A and B were determined as piericidin A1, 10-O-beta-D-glucoside and piericidin A1, 3'-O-D-glucoside on the basis of their spectral and chemical properties, respectively. Glucopiericidins were more potent in inhibiting antibody formation than piericidin A1 in vitro. In addition, these substances showed better antimicrobial activities than piericidin A1. Acute toxicities of these substances in mice were lower than that of piericidin A1. This indicates that D-glucose in glucopiericidin molecules is important in modulating their physiological activities.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3570963     DOI: 10.7164/antibiotics.40.149

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  11 in total

Review 1.  Discovery of novel drug targets and their functions using phenotypic screening of natural products.

Authors:  Junghwa Chang; Ho Jeong Kwon
Journal:  J Ind Microbiol Biotechnol       Date:  2015-09-12       Impact factor: 3.346

2.  Total synthesis of piericidin A1 and B1 and key analogues.

Authors:  Martin J Schnermann; F Anthony Romero; Inkyu Hwang; Eiko Nakamaru-Ogiso; Takao Yagi; Dale L Boger
Journal:  J Am Chem Soc       Date:  2006-09-13       Impact factor: 15.419

3.  Symbiotic Streptomycetes provide antibiotic combination prophylaxis for wasp offspring.

Authors:  Johannes Kroiss; Martin Kaltenpoth; Bernd Schneider; Maria-Gabriele Schwinger; Christian Hertweck; Ravi Kumar Maddula; Erhard Strohm; Ales Svatos
Journal:  Nat Chem Biol       Date:  2010-02-28       Impact factor: 15.040

Review 4.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

5.  Evolutionary stability of antibiotic protection in a defensive symbiosis.

Authors:  Tobias Engl; Johannes Kroiss; Marco Kai; Taras Y Nechitaylo; Aleš Svatoš; Martin Kaltenpoth
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-14       Impact factor: 11.205

Review 6.  The unique chemistry and biology of the piericidins.

Authors:  Xuefeng Zhou; William Fenical
Journal:  J Antibiot (Tokyo)       Date:  2016-06-15       Impact factor: 2.649

7.  Identification and Biological Activity of NFAT-133 Congeners from Streptomyces pactum.

Authors:  Wei Zhou; Priyapan Posri; Xiao-Jing Liu; Zhiran Ju; Wen-Jian Lan; Taifo Mahmud
Journal:  J Nat Prod       Date:  2021-09-14       Impact factor: 4.803

8.  An NF-κB-based high-throughput screen identifies piericidins as inhibitors of the Yersinia pseudotuberculosis type III secretion system.

Authors:  Miles C Duncan; Weng Ruh Wong; Allison J Dupzyk; Walter M Bray; Roger G Linington; Victoria Auerbuch
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

9.  Effective Generation of Glucosylpiericidins with Selective Cytotoxicities and Insights into Their Biosynthesis.

Authors:  Zengzhi Liu; Fei Xiao; Siqi Cai; Chunni Liu; Huayue Li; Ting Wu; Yuechen Jiang; Xin Wang; Qian Che; Tianjiao Zhu; Dehai Li; Wenli Li
Journal:  Appl Environ Microbiol       Date:  2021-06-11       Impact factor: 4.792

10.  Fermentation, Isolation, Structure, and antidiabetic activity of NFAT-133 produced by Streptomyces strain PM0324667.

Authors:  Asha A Kulkarni-Almeida; Manoja K Brahma; Prabhu Padmanabhan; Prabhu D Mishra; Rajashri R Parab; Nitin V Gaikwad; Chandni S Thakkar; Pradipta Tokdar; Prafull V Ranadive; Amrutha S Nair; Anagha A Damre; Umakant A Bahirat; Nitin J Deshmukh; Lalit S Doshi; Amol V Dixit; Saji D George; Ram A Vishwakarma; Kumar Vs Nemmani; Girish B Mahajan
Journal:  AMB Express       Date:  2011-11-21       Impact factor: 3.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.